Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Non-Current Assets (2016 - 2025)

International Stem Cell (ISCO) has disclosed Non-Current Assets for 16 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Assets fell 8.4% to $1.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $6.7 million, a 6.41% decrease, with the full-year FY2024 number at $1.6 million, down 13.7% from a year prior.
  • Non-Current Assets was $1.5 million for Q3 2025 at International Stem Cell, down from $1.7 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $3.0 million in Q1 2021 to a low of $1.5 million in Q3 2025.
  • A 5-year average of $2.1 million and a median of $2.1 million in 2023 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: decreased 23.88% in 2021, then rose 0.56% in 2025.
  • International Stem Cell's Non-Current Assets stood at $2.6 million in 2021, then decreased by 16.85% to $2.2 million in 2022, then dropped by 13.95% to $1.9 million in 2023, then dropped by 13.7% to $1.6 million in 2024, then dropped by 4.03% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for ISCO's Non-Current Assets are $1.5 million (Q3 2025), $1.7 million (Q2 2025), and $1.8 million (Q1 2025).